Pathogen Reduced Cryoprecipitated Fibrinogen Complex Visit product website ; INTERCEPT® Blood System for Platelets and Plasma Visit US SiteVisit International Site ; At Cerus, we are proud of our consistent and unwavering focus to secure blood safety around the globe. See Mission and Values ; Annual Report Cerus’ Annual Meeting of Stockholders will be held online on Wednesday, June 1, 2022 Read More Latest Press Releases 11/04/2022 Cerus Corporation to Participate in Upcoming Investor Conferences READ MORE 11/03/2022 Cerus Corporation Announces Third Quarter Financial Results READ MORE 11/02/2022 Cerus Corporation Announces Award of U.S. Department of Defense Funding for Development of Pathogen Reduced, Lyophilized Cryoprecipitate READ MORE 11/01/2022 Cerus Corporation Announces Health Canada Approval for INTERCEPT Blood System for Platelets with Seven-Day Storage READ MORE view all press releases
